LABTVSPFSA• 12 Months (Normalized)
LABT vs PFSA (Lakewood-Amedex Biotherapeutics Inc. vs Profusa Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $0.99
-98.86%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
PFSA Performance $2.05
+%
Profusa Inc.
Normalized Baseline0.00%
Alpha Spread Margin PFSA LEADS
-98.86 pts
PFSA outperforming by 98.86 percentage points
LABTPFSA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT PFSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | LABT Price | LABT Gain (%) | PFSA Price | PFSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $0.99 | -98.86% | $- | - | |
| Sep 28, 2026 | $1.15 | -98.67% | $- | - | |
| Sep 25, 2026 | $1.67 | -98.07% | $- | - | |
| Sep 24, 2026 | $1.83 | -97.88% | $- | - | |
| Sep 23, 2026 | $1.78 | -97.94% | $2.05 | -99.91% | +1.97% |
| Sep 22, 2026 | $1.99 | -97.70% | $2.17 | -99.90% | +2.20% |
| Sep 21, 2026 | $2.05 | -97.63% | $1.94 | -99.91% | +2.28% |
| Sep 18, 2026 | $1.99 | -97.70% | $1.91 | -99.91% | +2.21% |
| Sep 17, 2026 | $1.86 | -97.85% | $1.80 | -99.92% | +2.07% |
| Sep 16, 2026 | $2.09 | -97.58% | $1.78 | -99.92% | +2.34% |
| Sep 15, 2026 | $2.17 | -97.49% | $1.83 | -99.92% | +2.43% |
| Sep 14, 2026 | $2.12 | -97.55% | $2.59 | -99.88% | +2.33% |
| Sep 11, 2026 | $2.22 | -97.43% | $2.43 | -99.89% | +2.46% |
| Sep 10, 2026 | $2.05 | -97.63% | $2.50 | -99.89% | +2.26% |
| Sep 09, 2026 | $2.32 | -97.32% | $2.47 | -99.89% | +2.57% |
Page 1 of 17